Research Topics
| F DabisSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. F Dabis
Unité INSERM 330, Universite Victor Segalen Bordeaux 2, France
Lancet 353:786-92. 1999..Zidovudine reduces the rate of vertical transmission of HIV in non-breastfed populations. We assessed the acceptability, tolerance, and 6-month efficacy of a short regimen of oral zidovudine in African populations practising breastfeeding...
Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIVF Dabis
Unité INSERM no 330, Universite Victor Segalen Bordeaux 2, France
Health Policy Plan 15:34-42. 2000..The Ghent International Working Group on Mother-to-Child Transmission of HIV developed public health policy options to integrate these interventions into basic and maternal and child health (MCH) services...
Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000F Dabis
Unité INSERM no 330, Universite Victor Segalen Bordeaux, France
AIDS 14:1017-26. 2000..New findings from these trials are now becoming available, the implications of which, for population-based intervention programmes, need urgent consideration...
Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study GroupR Spira
Unité INSERM U 330, Universite Victor Segalen Bordeaux 2, Bordeaux, France
Pediatrics 104:e56. 1999....
International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIVV Leroy
Unité INSERM 330, Universite Victor Segalen Bordeaux 2, France
Lancet 352:597-600. 1998..We aimed to estimate the rate and timing of late postnatal transmission of HIV-1...
18-Month mortality and perinatal exposure to zidovudine in West AfricaF Dabis
Unité INSERM no 330, ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
AIDS 15:771-9. 2001..To study mortality in African children born to HIV-1-infected mothers exposed peripartum to zidovudine...
[HIV infection in Africa. Clinical and therapeutical research]R Salamon
Unité INSERM 330, Universite Victor Segalen Bordeaux 2
Presse Med 29:146-52. 2000..Ethical issues raised by the design and conduct of clinical research in Africa need a positive thinking to face the HIV African pandemic...
Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Côte d'IvoireK Castetbon
INSERM U 330, Universite Victor Segalen Bordeaux 2, 146 rue de Léo Saignat, 33076 Bordeaux Cedex, France
Am J Epidemiol 154:75-84. 2001..In Côte d'Ivoire where chemoprophylaxis of opportunistic infections has recently been recommended to be widely initiated on clinical criteria, such thresholds may help to screen patients with higher risks of mortality...
Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997E Malvy
Unité INSERM 330, Universite Victor Segalen Bordeaux 2, Hĵpital Saint André, Centre Hospitalier Universitaire de Bordeaux, France
J Am Coll Nutr 20:609-15. 2001..To assess the performance of weight related nutritional markers (reported involuntary weight loss greater than 10%, measured weight loss and body mass index-BMI-) in predicting HIV disease progression...
Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohortM de Pommerol
INSERM U897 and Institut de Santé Publique d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, France
Int J STD AIDS 22:67-72. 2011..25; 95% CI = 0.94-5.39). Earlier occurrence of menopause seems to be associated with factors already reported in HIV-negative women (IDU, ethnicity) and with HIV-related immunodeficiency...
HIV prevention in Latin America: reaching youth in ColombiaF Perez
Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, 146, rue Leo Saignat, 33076 Bordeaux, France
AIDS Care 15:77-87. 2003....
[Profile of HIV infected patients among blood donors in Abidjan, Côte d'Ivoire (1992-1999)]A K Minga
Projet ANRS 1220, Programme PAC CI, Abidjan, Cote d Ivoire
Bull Soc Pathol Exot 98:123-6. 2005..Rate of compliance of HIV-infected patients to follow-up has risen to 11% in 1992-1994 to 60% in 1997-1999 and will contribute to reach this aim...
Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002F Bonnet
Department of Internal Medicine and Infectious Diseases, Saint Andre Hospital, Bordeaux University Hospital, Bordeaux, France
HIV Med 6:198-205. 2005..To determine the factors associated with clinical progression (AIDS events and death) in antiretroviral-naive patients who have begun highly active antiretroviral therapy (HAART)...
Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002)K Martin
Bordeaux Regional Pharmacovigilance Center, Pharmacology Department, Victor Segalen University, Centre Hospitalier Universitaire, Bordeaux, France
HIV Med 5:421-6. 2004..CONCLUSIONS: In our study, the aetiology of clinical bone disorders seemed to be multifactorial, as almost all the patients had at least one possible risk factor in addition to HAART exposure...
Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patientsD Neau
Federation of Infectious and Tropical Diseases, Pellegrin Hospital, Place Amelie Raba Leon, 33 076 Bordeaux Cedex, France
HIV Med 5:171-3. 2004..As observed in patients not infected with HIV, the "anti-HBc-alone" serological profile could reflect essentially late immunity with undetectable anti-HBs antibodies. However, an occult HBV infection cannot be ruled out...
Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001F Bonnet
Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, 1 rue Jean Burguet, 33075 Bordeaux cedex, France
HIV Med 5:133-9. 2004..To describe the effect and tolerance of lipid-lowering drugs (LLD; fibrates and statins) in patients treated with highly active antiretroviral therapy (HAART)...
Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West AfricaD Bonard
Centre de Diagnostic et de Recherches sur le SIDA, CHU de Treichville, BP V3 Abidjan, Cote d Ivoire, West Africa
J Acquir Immune Defic Syndr 34:267-73. 2003..Follow-up of infected patients using both markers showed different results. The reliability of the HD p24 Ag assay is questionable for clinical and biologic management as a surrogate tool for measurement of HIV-1 RNA levels in Africa...
Carotid intima-media thickness is slightly increased over time in HIV-1-infected patientsP Mercie
Internal Medicine and Infectious Diseases, University Hospital of Bordeaux, France
HIV Med 6:380-7. 2005..In a 12-month follow-up study, we aimed to investigate changes in carotid intima-media thickness (IMT), a surrogate marker of atherosclerosis, and its determinants in HIV-1-infected patients...
Determinants of response to first HAART regimen in antiretroviral-naïve patients with an estimated time since HIV seroconversionR Thiebaut
INSERM E0338 Biostatistics, Bordeaux 2 University, Bordeaux, France
HIV Med 7:1-9. 2006..To study the determinants of immunological and virological response to highly active antiretroviral therapy (HAART) in naïve patients, adjusting for time since HIV-1 seroconversion...
HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002A Benard
INSERM U593, Institut de Santé Publique, d Épidémiologie et de Développement, Bordeaux, France
Int J Tuberc Lung Dis 10:378-83. 2006..To provide up-to-date and covariate-specific estimates on tobacco smoking prevalence in a representative cohort of French human immunodeficiency virus (HIV) 1 infected patients in 2002...
Community-based assessment of infant feeding practices within a programme for prevention of mother-to-child HIV transmission in rural ZimbabweJ Orne-Gliemann
ISPED Zimbabwe, 33 Lawson Avenue, Milton Park, Harare, Zimbabwe
Public Health Nutr 9:563-9. 2006..To describe the infant feeding practices and attitudes of women who used prevention of mother-to-child transmission of HIV (PMTCT) services in rural Zimbabwe...
Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004F Bonnet
CHU de Bordeaux, Services de Médecine Interne et Maladies Infectieuses, Bordeaux, France
HIV Med 8:547-54. 2007..The aim of the study was to characterize the causes, trends and determinants of severe morbidity in a large cohort of HIV-infected patients between 2000 and 2004...
Improved knowledge and practices among end-users of mother-to-child transmission of HIV prevention services in rural ZimbabweJ Orne-Gliemann
Institut de Santé Publique, d Épidémiologie et de Développement, Universite Victor Segalen, Bordeaux 2, Bordeaux, France
Trop Med Int Health 11:341-9. 2006..To evaluate the influence of a prevention of mother-to-child transmission of HIV advocacy and mobilization campaign on awareness and knowledge levels within the community...
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA StudyWendy P Bannister
Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, United Kingdom
J Acquir Immune Defic Syndr 48:324-33. 2008..To investigate prevalence of transmitted drug-resistant human immunodeficiency virus (TDR) and factors associated with TDR and to compare virological and CD4 count response to combination antiretroviral therapy...
Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapyOlivia Peuchant
Virology Laboratory, Bordeaux University Hospital, Bordeaux, France
AIDS 22:1417-23. 2008..We investigated the clinical relevance of the detection of majority and minority-resistant variants in an observational study in antiretroviral therapy naive, recently infected patients...
The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty boundsJ Stover
Futures Institute, Glastonbury, Connecticut, USA
Sex Transm Infect 84:i24-i30. 2008....
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studiesG Chene
Department of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH 3012, Bern, Switzerland
Lancet 362:679-86. 2003..We examined whether the initial virological and immunological response to highly active antiretroviral treatment (HAART) is prognostic in patients with HIV-1 who start HAART...
[Impaired fertility in women infected with HIV-1. Implications for sentinel serosurveillance]S Yaro
Centre Muraz, , 01 B.P. 153 Bobo-Dioulasso 01, Burkina Faso
Rev Epidemiol Sante Publique 49:221-8. 2001..These findings suggest adjusting antenatal clinic-based HIV sentinel surveillance data for age and fertility in order to derive a good estimate of the community HIV prevalence...
Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Côte d'Ivoire, West AfricaP Combe
Centre de Diagnostic et de Recherche sur le SIDA, PACCI, Centre Hospitalier Universitaire de Treichville, Abidjan,
Trans R Soc Trop Med Hyg 95:493-6. 2001..Our results confirm the high prevalence of HIV in Abidjan and the endemic situation of HBV infection. Furthermore, HCV infection is not infrequent in this developing country setting, not explained by sexual transmission...
Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998C Marimoutou
, , 146 rue Leo Saignat, 33076 Bordeaux, France
J Acquir Immune Defic Syndr 27:161-7. 2001..Based on our results, a high baseline HIV-RNA level is associated with isolated immunologic response; moreover, age should be of importance in treatment decision...
Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodologyA Alioum
INSERM U.330, , , , Bordeaux, France
Stat Med 20:3539-56. 2001..All estimates should be reported with confidence intervals. This standardized methodology that allows direct comparison between studies is now being applied to four randomized clinical trials...
Improving child health: the role of researchF Dabis
, , Case 11, , 33076 Bordeaux Cedex, France
BMJ 324:1444-7. 2002
Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999F Bonnet
Fédération de médecine interne, Maladies Infectieuses et Pathologie Tropicale, Hôpital Saint André Bordeaux, France
HIV Med 3:195-9. 2002..To describe the causes of death in HIV-infected patients in the era of highly active antiretroviral therapy (HAART)...
Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trialV Leroy
INSERM U330, ISPED, , Bordeaux, France
AIDS 15:517-22. 2001..CONCLUSION: High maternal viral load at inclusion strongly predicts MTCT of HIV in Africa. A short ZDV treatment regimen decreases significantly maternal viral load from its pretreatment level...
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patientsBernard Masquelier
Laboratoire de Virologie, Hopital Pellegrin, Bordeaux, France
Antimicrob Agents Chemother 46:2926-32. 2002..Genotypic and pK parameters should be used to optimize the virological response to LPV/r in PI-experienced patients and to avoid further viral evolution...
A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999F Bonnet
, Maladies Infectieuses et Pathologies Tropicales, , Centre Hospitalier Universitaire de Bordeaux, , Bordeaux, France
Clin Infect Dis 35:1231-7. 2002..Coinfection with HCV or HBV increased the risk of hepatotoxicity, which lead to the cautious use of nevirapine for such patients...
Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997C Binquet
, , , France
Am J Epidemiol 153:386-93. 2001..The findings support the potential for interruption of certain types of prophylaxis against opportunistic infections under reasonable conditions of duration of antiretroviral therapy and sustained CD4+ cell response...
Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997S Vandentorren
INSERM U330, , France
Eur J Epidemiol 17:7-10. 2001..7% to 72.2% (p = 0.007). CONCLUSION: HAART treatment has reduced the number and percentage of deaths due to AIDS-related causes among persons who died with HIV infection in South-western France...
Effect of early chemoprophylaxis with co-trimoxazole on nutritional status evolution in HIV-1-infected adults in Abidjan, Côte d'IvoireK Castetbon
INSERM U.330, , Bordeaux, France
AIDS 15:869-76. 2001....
Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patientsS Badiou
Biochemistry Department, University Hospital of Montpellier, F 34295 Montpellier, France
J Infect 57:47-54. 2008..In addition, we studied the relationship between metabolic syndrome (MS) and CIMT...
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohortMarc Arthur Loko
INSERM, U593, Bordeaux, France
Am J Gastroenterol 103:1973-80. 2008..Although an increasing number of noninvasive fibrosis markers are available in HCV-monoinfected patients, data on the performance of these tests in HIV-HCV-coinfected patients are lacking...
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaborationCaroline A Sabin
Lancet 371:1417-26. 2008..The excess risk does not seem to be explained by underlying established cardiovascular risk factors and was not present beyond 6 months after drug cessation...
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotypeL Castera
Department of Hepatology, Hopital Haut Leveque, Centre Hospitalier Universitaire Bordeaux, Pessac, France
Aliment Pharmacol Ther 26:1489-98. 2007..Significance of steatosis in HIV-HCV coinfection remains controversial...
[Causes of fever in adults infected by HIV-1. Ambulatory follow-up in the ANRS 059 trial in Abidjan, Ivory Coast]N Dakoury-Dogbo
CHU de Treichville, Programme PAC-CI, Abidjan
Presse Med 30:1674-80. 2001..The diffusion of antibiotic treatment algorithms adapted to the principle clinical syndromes encountered, might improve the treatment of adults infected by HIV consulting in sub-Saharian Africa...
Cardio- and cerebrovascular events in HIV-infected personsC A Sabin
, Italy
AIDS 18:1811-7. 2004..14-1.38; P < 0.0001). CONCLUSION: CART increases the risk of CCVD, and this increase is comparable with how CART affects the risk of MI. This finding is consistent with the hypothesis that atherosclerosis is a side-effect of CART...
15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and deliveryL Mandelbrot
Maternite Port Royal, Hopital Cochin, Paris, France UR091, Institut de Recherche pour le Développement IRD LPE, Marseille, France
Sex Transm Infect 78:267-70. 2002..To study mother to child HIV-1 transmission (MTCT) and infant mortality following benzalkonium chloride (BC) disinfection...
[Epidemiology of atherosclerotic cardiovascular risk in HIV-1 infected patients]R Thiebaut
Institut de Santé Publique, d Épidémiologie et de Développement, INSERM U593, Universite Victor Segalen, Bordeaux 33
Presse Med 32:1419-26. 2003..The main risk factors seem to be classical risk factors such as smoking habits, age and dyslipidemia that are partly due themselves to highly active antiretroviral treatments..
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarctionC A Sabin
Dept of Primary Care and Population Sciences, Royal Free and UC Medical School, Rowland Hill St, London, NW3 2PF, United Kingdom
Clin Infect Dis 46:1101-10. 2008..We evaluated changes in risk factors for CVD and the use of lipid-lowering therapy in HIV-infected individuals and assessed the impact of any changes on the incidence of myocardial infarction...
